FBXO44 antibody
Principal name
FBXO44 antibody
Alternative names for FBXO44 antibody
F-box only protein 44, FBG3, FBX30, FBX44, FBX6A, FBXO6A, F-box/G-domain protein 3, F-box protein FBX30
Ncbi ID
9606, NP_904320, NP_149438, NP_001014765.1, NP_001014765, NP_001155323.1, BC028884, NM_173401, NM_001161852, NM_183412, NM_001014765, NM_183413
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of FBXO44 antibody
- Kit Component:
- - KN305830G1, Fbxo44 gRNA vector 1 in pCas-Guide vector
- KN305830G2, Fbxo44 gRNA vector 2 in pCas-Guide vector
- KN305830D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Ilyin G, Serandour A, Pigeon C, Rialland M, Glaise D, Guguen-Guillouzo C. A new subfamily of structurally related human F-box proteins. Gene. 2002 Aug 21;296(1-2):11.
Western Blot analysis of FBXO44 expression in transfected 293T cell line (H00093611-T01) by FBXO44 MaxPab polyclonal antibody.Lane 1: FBXO44 transfected lysate(24.64 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of FBXO44 expression in transfected 293T cell line (H00093611-T02) by FBXO44 MaxPab polyclonal antibody.Lane 1: FBXO44 transfected lysate(25.70 KDa).Lane 2: Non-transfected lysate.
Detection of 30 ug of recombinant human full-length FBG3
(1.5ug/ml) staining of Human Brain (cerebellum) lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Host: Rabbit; Target Name: FBXO44; Sample Tissue: Fetal Heart lysates; Antibody Dilution: 1.0ug/ml
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA311609 | FBXO44 (Isoform 2) (C-term) antibody |
||||||
| Goat Anti-FBXO44 Antibody | |||||||
 |
Goat | Aff - Purified | Hu | E, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||